Figure 8

Uptake of [⁶⁴Cu]Cu-NOTA-B11-diabody in organs at multiple time points post-injection with major accumulation of the administered [⁶⁴Cu]Cu-NOTA-B11-diabody in liver, kidney and bladder in PD-L1_KO mouse bearing B16-F10 PD-L1_KO and B16-F10 hPD-L1+ melanoma tumors.